Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malathion Gel vs Nix for Head Lice
NCT00963508Phase 3Completed
- Start
- Aug 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of malathion in pediculosis capitis (2 arms). Primary endpoint: Proportion of Index Subjects Free of Any Lice at 14 days. Started Aug 2009; status: completed.
02
Drugs
malathion
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT00963508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00963508.